Table 71Summary clinical evidence profile: Comparison 4. Positive expiratory pressure (PEP) versus no airway clearance technique

Comparison 4. Positive expiratory pressure (PEP) compared to no airway clearance technique for CF
OutcomesIllustrative comparative risks* (95% CI)Relative effect (95% CI)No of Participants (studies)Quality of the evidence (GRADE)Comments
Assumed riskCorresponding risk
No airway clearance techniquePositive expiratory pressure (PEP)
Sputum dry weight (grams)
Follow-up: mean 2 days
The mean sputum dry weight in the control groups was 0.97The mean sputum dry weight in the PEP groups was 0.03 lower
(0.48 lower to 0.42 higher)
17
(Placidi 2006)
⊕⊕⊝⊝
low1
Sputum wet weight (grams)
Follow-up: mean 2 days
The mean sputum wet weight in the control groups was 13.98The mean sputum wet weight in the PEP groups was 1.8 higher
(1.72 lower to 5.32 higher)
17
(Placidi 2006)
⊕⊕⊕⊝
moderate2
Lung function - FEV1 % predicted
Scale from: 0 to 100
Follow-up: mean 2 days
The mean FEV1% predicted in the control groups was 60.3The mean FEV1% predicted in the PEP groups was 2.1 higher
(11.73 lower to 15.93 higher)
16
(Braggion 1995)
⊕⊝⊝⊝
very low3,4
Lung function - FEV1 (litres)
Follow-up: mean 2 days
The mean FEV1 (litres) in the control groups was 0.99The mean FEV1 (litres) in the PEP groups was 0.01 higher
(0.18 lower to 0.2 higher)
17
(Placidi 2006)
⊕⊕⊝⊝
low1
Lung Function FVC % predicted
Scale from: 0 to 100
Follow-up: mean 2 days
The mean FVC % predicted in the control groups was 81.6 % predictedThe mean FVC % predicted in the PEP groups was 1.2 higher
(12.88 lower to 15.28 higher)
16
(Braggion 1995)
⊕⊝⊝⊝
very low1,3
Lung function - FVC (litres
Follow-up: mean 2 days
The mean FVC (litres) in the control groups was 1.96The FVC in the PEP groups was 0.05 higher
(0.35 lower to 0.45 higher)
17
(Placidi 2006)
⊕⊕⊝⊝
low1
Oxygen saturation - Spo2 %
Scale from: 0 to 100
Follow-up: mean 2 days
The mean oxygen saturation (spo2) in the control groups was 94.6The mean oxygen saturation (spo2) in the PEP groups was 0.3 higher
(0.58 lower to 1.18 higher)
17
(Placidi 2006)
⊕⊕⊕⊝
moderate2
*

The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).

Abbreviations: CI: confidence interval; FEV1: forced expiratory volume in 1 second; FVC: forced vital capacity; MD: mean difference; SpO2: peripheral capillary oxygen saturation

1

The quality of the evidence was downgraded by 2 due to very serious imprecision as 95% CI crossed 2 default MIDs

2

The quality of the evidence was downgraded by 1 due to serious imprecision as 95% CI crossed a default MID

3

The quality of the evidence was downgraded by 2 due to lack of blinding, attrition bias and reporting bias

4

The quality of the evidence was downgraded by 2 due to very serious imprecision as 95% CI crossed 2 clinical MIDs

From: 9, Pulmonary monitoring, assessment and management

Cover of Cystic Fibrosis
Cystic Fibrosis: Diagnosis and management.
NICE Guideline, No. 78.
National Guideline Alliance (UK).
Copyright © NICE 2017.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.